Predictive value of hematological indices on incidence and severity of pulmonary embolism in COVID-19 patients.

Hanieh RadkhahEnsieh Sadat MansouriShiva Rahimipour AnarakiMilad Gholizadeh MesgarhaAli SheikhyMohamad Mehdi KhadembashiriMohamad Amin KhadembashiriMohamad EslamiTara MahmoodiBehnaz InanlooArash Pour Mohammad

Published in: Immunity, inflammation and disease (2023)

Among hematological indices, NLR and more precisely PLR are cost-effective and simply calculable markers that can assist physicians in determining whether or not COVID-19 patients with clinically probable PTE require CT angiography and the higher neutrophil count can be employed as an indicator of PTE severity in COVID-19 patients. Further large multicenter and prospective studies are warranted to corroborate these observations.

Keyphrases

pulmonary embolism
sars cov
inferior vena cava
coronavirus disease
primary care
respiratory syndrome coronavirus
risk factors
cross sectional
peripheral blood
case control
clinical trial
double blind